Our Global Organization
U.S. Generic Products Division delivers high-quality generic products that offer patients improved access and affordable options to medications that enhance their lives. Known for our expertise for advanced, complex and niche pharmaceuticals, Mayne Pharma offers a robust catalog of products addressing a broad range of therapeutic treatment areas. Learn more about our generic products.
U.S. Specialty Brands Division is responsible for the marketing and distribution of branded pharmaceutical products within the United States, which currently includes Doryx® Fabior® and Sorilux®. More than 120 sales professionals represent Mayne Pharma across the country, educating health-care providers and driving the adoption of our key dermatology products. Learn more about our specialty branded products.
Metrics Contract Services is a trusted partner in contract pharmaceutical development and manufacturing services to innovative pharmaceutical companies. With a focus on solid oral dosage forms, Metrics Contract Services offers technical capabilities that include highly potent, cytotoxic and unstable compounds, and products with poor bioavailability, for which we offer an impressive proprietary portfolio of advanced delivery methods. Learn more about Metrics Contract Services.
Mayne Pharma International’s goal is to take Mayne Pharma’s drug-delivery expertise to markets around the world by working with a network of local partners. In Australia, the sales and marketing team is one of Australia’s leading specialty pharma companies, bringing new and patient-centric products to Australia that often are overlooked by larger companies. The International R&D team is based at the company’s R&D and manufacturing operations in Salisbury, South Australia, and works to bring new generic and specialty products to patients around the world.